A new randomized, double-blind, sham-controlled clinical trial reports that a non-invasive, home-based light therapy produced measurable improvements in objective cognitive performance in adults under ...

A new randomized clinical trial has revealed that just 24 minutes of listening to specially designed music paired with ...

The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease, having met the primary ...

Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m2 or greater - ...

Onvansertib in combination with both chemo/bev regimens was well-tolerated. There were no major or unexpected toxicities observed and no additive adverse events. Grade 3 or higher adverse events were ...

The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of ...